Haihe Biopharma
Pharmaceutical company specialized in innovative oncology drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€900m (Public information from Jul 2020)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$147m | Series B | ||
CNY1.2b Valuation: CNY7.2b | Series B | ||
| Total Funding | €283m | ||
Related Content
Recent News about Haihe Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.